FDA Risk Communication Committee Recommends Clarity, Predictability
This article was originally published in The Tan Sheet
Executive Summary
FDA's Risk Communication Advisory Committee submitted six broad recommendations Nov. 12 with an emphasis on making product risk announcements more predictable and available more quickly
You may also be interested in...
Doctor Survey Results Will Inform FDA Policy On Risk Communication
Findings from an FDA survey of physicians about their use and perceptions of emerging drug risk information could add a new tenor to the debate about the value of communicating early risk signals
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands